Astria Therapeutics, Inc. (ATXS)

NASDAQ

$--

(--)

Market Closed

Astria Therapeutics, Inc. (ATXS) Live Price Chart

Last updated: ⁦2026-10-21 06:00:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Astria Therapeutics, Inc. (ATXS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Astria Therapeutics, Inc. (ATXS) Latest Closing Stock Price

Astria Therapeutics, Inc. (ATXS) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, ATXS traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Astria Therapeutics, Inc. (ATXS) 7-Day Stock Price Change

Over the past seven days, Astria Therapeutics, Inc. (ATXS) moved from $12.74 to $12.58, representing a decline of 1.26% ($0.16).

The stock traded between $12.24 and $12.86 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.29 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Astria Therapeutics, Inc. (ATXS)?

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Astria Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	78
Exchange	NASDAQ
Company Website	https://www.astriatx.com

How to Buy Astria Therapeutics, Inc. (ATXS) Stock on MEXC

Eligible investors can buy real shares of Astria Therapeutics, Inc. (ATXS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ATXS and Place Your Order

Open the RealStocks trading page and search for ATXS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Astria Therapeutics, Inc. (ATXS) stock price today?

Astria Therapeutics, Inc. (ATXS) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is ATXS stock going up or down today?

As of --, ATXS is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is ATXS pre-market price?

As of --, ATXS is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ATXS after-hours price?

As of --, ATXS is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ATXS stock trading now?

ATXS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ATXS sit relative to its 52-week high and low?

Over the past 52 weeks, ATXS has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Astria Therapeutics, Inc. in?

Astria Therapeutics, Inc. (ATXS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Astria Therapeutics, Inc.'s market capitalization and where is it listed?

Astria Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ATXS valued in terms of P/E ratio and EPS?

ATXS trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Astria Therapeutics, Inc. pay a dividend?

Astria Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.